Innovator Founder ILR: what counts as £50,000 invested and actively spent?

01 / The legal test

£50,000 is 1 achievement with 2 operative conditions.

INNF 17.1(f)(i) requires at least £50,000 to have been invested into the business and actively spent furthering the business. Both conditions must be established. A transfer into the company without qualifying expenditure addresses only the first. Expenditure paid from ordinary trading income without identifying the investment relied upon may leave the injection and attribution questions unresolved.

The investment criterion counts as 1 qualifying achievement. INNF 17.2 expressly prevents £100,000 from being divided into 2 instances of the same criterion. The founder must establish another distinct achievement, together with the wider settlement requirements: significant progress against the endorsed plan, active trading, 12 month sustainability, an active key role, the qualifying period, continuous residence, knowledge of life and suitability.

The cited provisions do not say that the company must be loss making, that the £50,000 must remain on the balance sheet or that each pound must buy a capital asset. The question is whether the required investment occurred and was actively used to advance the endorsed venture. That conclusion should follow the Rules and current guidance, not a generic accounting label.

02 / The injection

A valuation, facility or promise is not the cash injection described by the guidance.

The endorsing body guidance says the body should be able to identify a cash injection made by or clearly secured by the applicant into the business. This is narrower than saying the company has access to £50,000. An undrawn facility, unsigned subscription, conditional grant or investor promise may be commercially valuable, but it does not show that cash was injected into the venture and then spent.

The receipt should be identifiable in the company's bank record and books. Circular transfers, short term deposits returned to the sender, movements between accounts of the same company and repeated presentation of the same funds do not create additional investment. The evidence should show the economic transaction rather than only a favourable balance on 1 selected date.

The Rules do not prescribe a universal deadline measured from the first endorsement, nor do they say that only post visa expenditure can count. Timing still matters. A founder relying on earlier funding must connect it to the endorsed business venture and demonstrate the later active expenditure. Historic personal costs incurred before the company existed may be harder to characterise as investment into that company unless the legal and accounting treatment genuinely supports it.

03 / Legal form

Equity is not the only conceivable form, but the label does not decide the immigration result.

A share subscription provides a familiar route: the investor pays the company and receives shares under the corporate documents. A founder loan can also create a real cash injection. The current settlement wording does not state that only equity qualifies. The loan agreement, bank transfer and accounts must nevertheless show a genuine injection into the endorsed business, not a temporary accommodation or a payment made to somebody else.

Third party investment, grants and group funding require a more careful attribution analysis. The guidance refers to a cash injection made by or clearly secured by the applicant. It should not be assumed that any money received by the company is automatically the founder's qualifying investment. The file should explain what the applicant did to secure it, the binding transaction, who supplied the funds and why the endorsing body can attribute the injection to that applicant.

This distinction is especially important after an institutional round. A founder may have originated the relationship and led the raise, while the subscription agreement and board papers present the financing as a company process. That may support attribution, but the conclusion should be tested against the actual documents. Immigration drafting should not rewrite the corporate record after the event.

04 / Active expenditure

Money in the account is available capital, not money actively spent.

The second limb prevents the criterion from being met by parking £50,000 in the business shortly before settlement. The venture must have deployed at least that amount. A board approved budget, purchase order or signed future contract may demonstrate intention; it does not necessarily establish completed expenditure. The payment record and underlying transaction should show what has actually occurred by the endorsement assessment.

Ordinary operating expenditure can further a business. Product development, staff costs, specialist equipment, regulatory work, premises, infrastructure and a properly evidenced market launch may all be capable of advancing the venture on their facts. The Rules do not publish a closed list or say that only capital expenditure counts. Equally, every company payment is not automatically qualifying merely because it appears in the ledger.

Founder remuneration, related party charges, debt repayment, refundable deposits and large prepayments deserve particular examination. None should be accepted or rejected solely by category. Ask what value the business received, whether the transaction was genuine and arm's length where relevant, whether the expenditure advanced the endorsed venture, and whether any refund, asset transfer or repayment changed the economic position.

A transfer to another account controlled by the company is not ordinarily expenditure merely because cash left the first account. Payment to a group company also needs evidence of the goods or services actually supplied to the endorsed business. The test concerns furthering the business venture, not moving money around a structure.

05 / Traceability

The settlement file needs a bridge between funding and expenditure.

Company accounts may establish that capital and expenditure exist, but annual totals can conceal the sequence and purpose needed for the immigration test. A credible schedule should identify each injection relied upon, its date, legal form, source and receipt, then map the qualifying expenditure to invoices, contracts, payroll or other primary records.

The exercise is not necessarily a literal tracing of serial numbered pounds through a mixed bank account. It is a reconciled evidential account showing that at least £50,000 was injected and that the venture then incurred at least £50,000 of active, business furthering spend. Where investment and trading receipts are commingled, explain the accounting method and avoid claiming more precision than the records support.

The schedule should reconcile to the bank statements, general ledger and signed accounts. Material differences between management accounts, filed accounts, tax records and the settlement narrative should be resolved before submission. A founder cannot repair a missing transaction by describing it more emphatically in a witness statement.

06 / Business purpose

Expenditure should be connected to the endorsed venture, not merely to the company.

The criterion refers to furthering the business. The strongest record explains how the spend advanced product delivery, regulatory readiness, market entry, revenue capability, operational capacity or another evidenced part of the endorsed plan. The purpose should be commercially intelligible and consistent with the venture that the endorsing body has monitored.

A company may legitimately pivot, add a product line or revise its route to market. If the expenditure relates to a materially changed proposition, settlement preparation should address the change rather than assuming the original endorsement automatically covers it. The question is not whether the invoice is a real business expense in accounting terms, but whether the investment was actively spent furthering the endorsed venture on which settlement is sought.

The founder should also preserve the active role evidence. Paying suppliers and raising capital can be important contributions, but settlement independently requires an active key role in day to day management and development. The investment criterion cannot convert a passive investor into a qualifying Innovator Founder.

07 / Founder teams

The same £50,000 should not be copied into 2 founder applications.

INNF 17.3 prevents Innovator Founder team members who are applying for, or have received, settlement from sharing the same means of meeting the criteria. The published example concerns jobs, but the rule is not confined to employment. If 2 founders in the same venture both propose to rely on investment, the evidence must establish distinct qualifying means for each applicant rather than presenting the same company wide £50,000 twice.

In practice, that calls for applicant level attribution. Separate £50,000 injections and corresponding active expenditure may provide a clearer case than a general statement that the company raised more than £100,000. The funding documents, cap table, loan accounts and settlement schedule should identify which injection is relied upon by which founder and why each is made by or clearly secured by that person.

Do not assume that multiplying the company total solves every team case. If the whole round was secured collectively and the same expenditure is relied upon for both applicants, the attribution may remain contested. It may be more defensible for different founders to rely on genuinely separate achievements where the business record supports them. That is a planning decision for the actual evidence, not a device for dividing identical results on paper.

08 / Evidence

There is no published universal bundle; there should still be an auditable file.

Neither INNF 17.1(f)(i) nor the cited endorsing body guidance publishes a mandatory document checklist for every investment case. The appropriate evidence will depend on the funding instrument, banking arrangements, expenditure and founder team. The following architecture is prudent preparation, not an additional Immigration Rule.

Start with the investment documents and source record: subscription or loan agreement, grant terms where relevant, board and shareholder approvals, cap table, statutory filings, company bank receipt and the evidence needed for source of wealth and mode of transfer due diligence. Then build the spend record: general ledger extract, bank payments, invoices, contracts, payroll records and asset evidence, cross referenced to a concise schedule.

Complete the file with management and filed accounts, corporation tax records where relevant, a business plan mapping note and an accountant's reconciliation if useful. An accountant can verify the books and cash flows. They should not be asked to give an immigration conclusion outside their expertise. The founder and legal team should identify the legal criterion; the endorsing body must decide whether it is satisfied for endorsement.

09 / Settlement strategy

Choose the criterion early enough to finish the expenditure and prove a second achievement.

A founder approaching the third anniversary with £50,000 still held has a timing problem, not simply a drafting problem. Accelerated or artificial expenditure may weaken commercial discipline and produce poor evidence of business purpose. The correct response may be to assess extension timing, another achievement already supported by the venture or a properly planned period in which genuine expenditure can be completed.

The investment criterion must also sit beside a second distinct achievement. Customer growth, qualifying R&D and IP, revenue and job creation each have separate conditions. Select the pair that the business has actually achieved and can evidence. Settlement planning should not encourage the venture to spend money badly simply to reach a threshold while ignoring sustainability for the following 12 months.

The final endorsement must be no more than 3 months old when the settlement application is made. Permission expiry, endorsement timing, continuous residence and the second criterion should be modelled together. If the settlement evidence will not be ready, address the position before the current permission becomes urgent.

Practical questions.